EpiVax's Grant - XII Round

EpiVax raised a round of funding on October 09, 2007. Investors include Juvenile Diabetes Research Foundation International.

EpiVax, is a privately held biotechnology company focused on the development of vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. The immunoinformatics team at EpiVax has …

Articles about EpiVax's Grant - XII Round: